InnovHeart fetches Series B
Milan, Italy and Newton, Massachusetts-based InnovHeart, a developer of novel transcatheter mitral valve replacement systems for the treatment of mitral valve disease, has raised 20 million euros in Series B financing.
Milan, Italy and Newton, Massachusetts-based InnovHeart, a developer of novel transcatheter mitral valve replacement systems for the treatment of mitral valve disease, has raised 20 million euros in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination